Annual Total Liabilities
$14.07 M
+$1.95 M+16.12%
December 1, 2023
Summary
- As of February 10, 2025, SKYE annual total liabilities is $14.07 million, with the most recent change of +$1.95 million (+16.12%) on December 1, 2023.
- During the last 3 years, SKYE annual total liabilities has risen by +$11.85 million (+533.63%).
- SKYE annual total liabilities is now -19.68% below its all-time high of $17.52 million, reached on December 1, 2018.
Performance
SKYE Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$5.73 M
-$8.72 M-60.34%
September 1, 2024
Summary
- As of February 10, 2025, SKYE quarterly total liabilities is $5.73 million, with the most recent change of -$8.72 million (-60.34%) on September 1, 2024.
- Over the past year, SKYE quarterly total liabilities has dropped by -$10.22 million (-64.07%).
- SKYE quarterly total liabilities is now -82.41% below its all-time high of $32.59 million, reached on March 1, 2019.
Performance
SKYE Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
SKYE Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +16.1% | -64.1% |
| 3 y3 years | +533.6% | -6.8% |
| 5 y5 years | -19.7% | -6.8% |
SKYE Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +252.6% | -64.1% | +43.6% |
| 5 y | 5-year | at high | +871.4% | -64.1% | +295.7% |
| alltime | all time | -19.7% | >+9999.0% | -82.4% | >+9999.0% |
Skye Bioscience Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $5.73 M(-60.3%) |
| Jun 2024 | - | $14.45 M(-9.4%) |
| Mar 2024 | - | $15.95 M(+13.4%) |
| Dec 2023 | $14.07 M(+16.1%) | $14.07 M(+1.2%) |
| Sep 2023 | - | $13.91 M(+38.7%) |
| Jun 2023 | - | $10.03 M(+7.0%) |
| Mar 2023 | - | $9.37 M(-22.7%) |
| Dec 2022 | $12.12 M(+203.7%) | $12.12 M(+96.9%) |
| Sep 2022 | - | $6.15 M(+16.8%) |
| Jun 2022 | - | $5.27 M(+24.3%) |
| Mar 2022 | - | $4.24 M(+6.2%) |
| Dec 2021 | $3.99 M(+79.7%) | $3.99 M(+16.6%) |
| Sep 2021 | - | $3.42 M(+6.4%) |
| Jun 2021 | - | $3.22 M(+10.2%) |
| Mar 2021 | - | $2.92 M(+31.5%) |
| Dec 2020 | $2.22 M(+53.3%) | $2.22 M(-11.0%) |
| Sep 2020 | - | $2.50 M(-24.8%) |
| Jun 2020 | - | $3.32 M(+39.8%) |
| Mar 2020 | - | $2.38 M(+64.0%) |
| Dec 2019 | $1.45 M(-91.7%) | $1.45 M(-92.0%) |
| Sep 2019 | - | $18.13 M(+23.1%) |
| Jun 2019 | - | $14.72 M(-54.8%) |
| Mar 2019 | - | $32.59 M(+86.0%) |
| Dec 2018 | $17.52 M | $17.52 M(+54.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $11.32 M(+10.0%) |
| Jun 2018 | - | $10.29 M(+15.4%) |
| Mar 2018 | - | $8.91 M(+556.6%) |
| Dec 2017 | $1.36 M(-23.5%) | $1.36 M(-44.6%) |
| Sep 2017 | - | $2.45 M(+8.2%) |
| Jun 2017 | - | $2.26 M(+22.5%) |
| Mar 2017 | - | $1.85 M(+4.1%) |
| Dec 2016 | $1.77 M(-41.6%) | $1.77 M(+3.7%) |
| Sep 2016 | - | $1.71 M(+28.0%) |
| Jun 2016 | - | $1.34 M(-60.2%) |
| Mar 2016 | - | $3.36 M(+10.5%) |
| Dec 2015 | $3.04 M(+279.1%) | $3.04 M(-13.5%) |
| Sep 2015 | - | $3.52 M(+109.0%) |
| Jun 2015 | - | $1.68 M(+108.4%) |
| Mar 2015 | - | $807.10 K(+0.6%) |
| Dec 2014 | $801.90 K(+1187.2%) | $801.90 K(+129.4%) |
| Sep 2014 | - | $349.50 K(+304.0%) |
| Jul 2014 | - | $86.50 K(+75.5%) |
| Apr 2014 | - | $49.30 K(-8.4%) |
| Jan 2014 | - | $53.80 K(-13.6%) |
| Oct 2013 | $62.30 K(+1348.8%) | $62.30 K(-3.0%) |
| Jul 2013 | - | $64.20 K(-6.7%) |
| Apr 2013 | - | $68.80 K(+1500.0%) |
| Oct 2012 | $4300.00 | $4300.00 |
FAQ
- What is Skye Bioscience annual total liabilities?
- What is the all time high annual total liabilities for Skye Bioscience?
- What is Skye Bioscience annual total liabilities year-on-year change?
- What is Skye Bioscience quarterly total liabilities?
- What is the all time high quarterly total liabilities for Skye Bioscience?
- What is Skye Bioscience quarterly total liabilities year-on-year change?
What is Skye Bioscience annual total liabilities?
The current annual total liabilities of SKYE is $14.07 M
What is the all time high annual total liabilities for Skye Bioscience?
Skye Bioscience all-time high annual total liabilities is $17.52 M
What is Skye Bioscience annual total liabilities year-on-year change?
Over the past year, SKYE annual total liabilities has changed by +$1.95 M (+16.12%)
What is Skye Bioscience quarterly total liabilities?
The current quarterly total liabilities of SKYE is $5.73 M
What is the all time high quarterly total liabilities for Skye Bioscience?
Skye Bioscience all-time high quarterly total liabilities is $32.59 M
What is Skye Bioscience quarterly total liabilities year-on-year change?
Over the past year, SKYE quarterly total liabilities has changed by -$10.22 M (-64.07%)